Core Insights - Baird Medical has launched its Microwave Ablation technology at Bakersfield Memorial Hospital, marking a significant step in its U.S. market penetration and commitment to enhancing patient access to advanced care [1][2] - The inaugural procedure for benign thyroid tumors was successfully performed, showcasing the technology's efficiency and safety in a high-volume hospital setting [1] - This launch aligns with Baird Medical's strategic commercial roadmap, aiming to drive the adoption of interventional therapies and improve patient care standards [2] Company Overview - Baird Medical Investment Holdings Ltd. specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [2] - The company is FDA 510(k)-certified and has its solutions utilized in over 30 prestigious hospitals across the U.S., including Mayo Clinic and UCSF Medical Center [2] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [2]
Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital